Chronic parvovirus B19 infection leading to red cell aplasia following treatment of Hodgkin lymphoma.
Poplar
Sarah
S
Department of Haematology, Taunton and Somerset NHS Foundation Trust, UK. sarah.poplar@hotmail.co.uk <sarah.poplar@hotmail.co.uk>
Allford
Sarah
S
Rooney
Nicholas
N
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols; D002908:Chronic Disease; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D016867:Immunocompromised Host; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008297:Male; D010322:Parvoviridae Infections / Q000209:etiology* / Q000628:therapy; D016732:Parvovirus B19, Human / Q000302:isolation & purification*; D016133:Polymerase Chain Reaction; D012010:Red-Cell Aplasia, Pure / Q000628:therapy / Q000821:virology*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D016756:Immunoglobulins, Intravenous